Pasar al contenido principal

DETECCION PRECOZ DE INFECCIONES CRONICAS EN POBLACION INMIGRANTE

PI17/02020

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2017
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (ISGLOBAL)
Centro realización FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA (ISGLOBAL)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Estimating the prevalence of chronic infections among asymptomatic migrants, results of a screening programme in Catalonia, Spain

  • Cruz, Angeline
  • Martínez-Perez, Angela
  • Almuedo-Riera, Alex
  • Roca Saumell, Carme
  • Gigante Lopez, Marina
  • Gasch, Oriol|||0000-0001-8518-458X
  • Falcó, Gemma
  • Jiménez-Lozano, Ana
  • Sanchez-Collado, Consol
  • Alonso Padilla, Julio|||0000-0003-4466-7969
  • Hurtado, Juan Carlos
  • Álvarez-Martínez, Miriam J.
  • Casellas, Aina|||0000-0003-4939-8411
  • Requena-Méndez, Ana|||0000-0002-4422-241X
Migrants are disproportionately affected by several infectious diseases differing the risk within migrant groups. This study aimed to estimate the prevalence of six chronic infections in asymptomatic migrants attended at primary care or specialized units where health assessments are offered. A multicentric cross-sectional study was conducted to estimate the prevalence of human immunodeficiency virus (HIV), hepatitis B and C virus, Strongyloides stercoralis, Schistosoma spp., and Trypanosoma cruzi infections in the migrant population who participated in a screening programme implemented at six primary health care centres, and two infectious diseases outpatient clinics in Catalonia, Spain. Of the 314 recruited migrants, 284 (90.4 %) were tested for at least one infection. The prevalence of the infections was as follows: 1.8 % for HIV, 1.8 % for chronic hepatitis B virus, 14.1 % for previous exposure to a hepatitis B virus infection, 0.4 % for hepatitis C virus infection, 2.6 % for S.stercoralis infection, and 7.0 % for T.cruzi infection. No cases infected with Schistosoma spp. were reported. A higher prevalence of HIV, hepatitis B and C virus was observed in Sub-Saharan Africans, whereas a higher prevalence of S.stercoralis and T.cruzi infections was reported in migrants from Latin-America and the Caribbean. Findings suggest a high burden of the studied infections, including parasitic infections, in the migrant population with variations within migrant groups based on areas of birth.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evaluation of the accuracy of a multi-infection screening test based on a multiplex immunoassay targeting imported diseases common in migrant populations

  • Aguilar, Ruth
  • Cruz, Angeline
  • Jiménez, Alfons
  • Almuedo, Alex
  • Roca Saumell, Carme
  • Gigante López, Marina
  • Gasch, Oriol
  • Falcó, Gemma
  • Jiménez-Lozano, Ana
  • Martínez-Pérez, Angela
  • Sánchez-Collado, Consol
  • Tedesco, Andrea
  • López López, Manuel Carlos
  • Pinazo, María Jesús
  • Leonel, Thais
  • Bisoffi, Zeno
  • Färnert, Anna
  • Dobaño, Carlota
  • Requena-Méndez, Ana
[Background]We aimed to evaluate the performance of a novel multiplex serological assay, able to simultaneously detect IgG of six infections, as a screening tool for imported diseases in migrants., [Methods] Six panels of 40 (n = 240) anonymized serum samples with confirmed infections were used as positive controls to assess the multiplex assay's sensitivity. One panel of 40 sera from non-infected subjects was used to estimate the seropositivity cutoffs, and 32 non-infected sera were used as negative controls to estimate each serology's sensitivity and specificity. The multi-infection screening test was validated in a prospective cohort of 48 migrants from endemic areas.The sensitivity of the Luminex assay was calculated as the proportion of positive results over all positive samples identified by reference tests. The specificity was calculated using 32 negative samples. Uncertainty was quantified with 95 % confidence intervals using receiver operating characteristic analyses., [Results] The sensitivity/specificity were 100 %/100 % for HIV (gp41 antigen), 97.5 %/100 % for Hepatitis B virus (HBV-core antigen), 100 %/100 % for Hepatitis C virus (HCV-core antigen), 92.5 %/90.6 % for strongyloidiasis [31-kDa recombinant antigen (NIE)], 97.5 %/100 % for schistosomiasis (combined serpin Schistosoma mansoni and S.haematobium antigens) and 95 %/90.6 % for Chagas disease [combined Trypanosoma cruzi kinetoplastid membrane protein-11 (KMP11) and paraflagellar rod proteins 2 (PFR2) antigens]. In the migrant cohort, antibody response to the combination of the T.cruzi antigens correctly identified 100 % individuals, whereas HBV-core antigen correctly identified 91.7 % and Strongyloides-NIE antigen 86.4 %., [Conclusions] We developed a new, robust and accurate 8-plex Luminex assay that could facilitate the implementation of screening programmes targeting migrant populations., This study was supported by two grants from Instituto de Salud Carlos III (ISCIII), co-financed by the European Regional Development Fund (FEDER) from the European Union, through the “Fondo de Investigación para la Salud (FIS)”, PI17/02020 and PI20/00866. This research team was supported by CIBER-Consorcio Centro de Investigación Biomédica en Red-(CB 2021), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea. ISGlobal receives support from the Spanish Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program. Authors from IRCCS Sacro Cuore Don Calabria Hospital were supported by the Italian Ministry of Health “Fondi Ricerca corrente-L2P4”. ARM receives funding from the Strategic Research Program in Epidemiology at Karolinska Institutet. MCL was supported by the Programa Estatal I + D + I, Spanish Ministry of Science and Innovation and FEDER (PID2019-109090RB-I00/AEI/10.13039/501100011033)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2018-000806-S), Peer reviewed